Article

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-catenin

2020-07-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background：</bold>Breast cancer is the most common malignant tumor and the leading cause of death in women. Chemotherapy is one of the most important treatments for breast cancer. However, the development of chemotherapy resistance is the main cause of 20-30% of breast cancer patients developing metastasis, leading to death. MCL-1, an anti-apoptotic protein, has not been found to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ce93ba66-ae85-558b-9e77-ea689655c958
DOI: 10.21203/rs.3.rs-46792/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-cateninDOI 10.21203/rs.3.rs-46792/v1Read

MCL-1 plays an oncogenic role in breast cancer by modulating chemoresistance and stemness properties by activating Wnt/β-cateninSemantic proximity Read

Mcl‐1 targeting could be an intriguing perspective to cure cancerSemantic proximity Read

Dll1+ quiescent tumor stem cells drive chemoresistance in breast cancer through NF-κB survival pathwaySemantic proximity Read

MCL-1 is a prognostic indicator and drug target in breast cancerSemantic proximity Read

MiR-519d impedes cisplatin-resistance in breast cancer stem cells by down-regulating the expression of MCL-1Semantic proximity Read

Breast cancer dependence on MCL-1 is due to its canonical anti-apoptotic functionSemantic proximity Read

PRMT1 regulates EGFR and Wnt signaling pathways and is a promising target for combinatorial treatment of breast cancerSemantic proximity Read

LRH1 enhances cell resistance to chemotherapy by transcriptionally activating MDC1 expression and attenuating DNA damage in human breast cancerSemantic proximity Read

LncRNA FLVCR1-AS1 promotes proliferation, migration and activates Wnt/β-catenin pathway through miR-381-3p/CTNNB1 axis in breast cancerSemantic proximity Read

Toll-Like Receptor 2 Promotes Breast Cancer Progression and Resistance to ChemotherapySemantic proximity Read

Long noncoding RNA DLEU2 and ROR1 pathway induces epithelial-to-mesenchymal transition and cancer stem cells in breast cancerSemantic proximity Read

MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer- associated fibroblastsSemantic proximity Read